CSII - Cardiovascular Systems, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.54B
Enterprise Value 31.45B
Trailing P/E 751.19
Forward P/E 1554.00
PEG Ratio (5 yr expected) 1-28.10
Price/Sales (ttm)6.46
Price/Book (mrq)10.90
Enterprise Value/Revenue 36.06
Enterprise Value/EBITDA 6280.44

Trading Information

Stock Price History

Beta (3Y Monthly) 1.28
52-Week Change 326.87%
S&P500 52-Week Change 36.70%
52 Week High 346.52
52 Week Low 324.84
50-Day Moving Average 342.16
200-Day Moving Average 337.13

Share Statistics

Avg Vol (3 month) 3284.05k
Avg Vol (10 day) 3395.79k
Shares Outstanding 534.83M
Float 33.55M
% Held by Insiders 13.61%
% Held by Institutions 186.94%
Shares Short (Jun 28, 2019) 41.57M
Short Ratio (Jun 28, 2019) 46.36
Short % of Float (Jun 28, 2019) 44.66%
Short % of Shares Outstanding (Jun 28, 2019) 44.51%
Shares Short (prior month May 31, 2019) 42.08M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 210/1
Last Split Date 3Feb 26, 2009

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.84%
Operating Margin (ttm)0.71%

Management Effectiveness

Return on Assets (ttm)0.52%
Return on Equity (ttm)1.50%

Income Statement

Revenue (ttm)238.94M
Revenue Per Share (ttm)7.14
Quarterly Revenue Growth (yoy)13.90%
Gross Profit (ttm)177.56M
EBITDA 5.17M
Net Income Avi to Common (ttm)1.99M
Diluted EPS (ttm)0.06
Quarterly Earnings Growth (yoy)84.10%

Balance Sheet

Total Cash (mrq)115.74M
Total Cash Per Share (mrq)3.32
Total Debt (mrq)21M
Total Debt/Equity (mrq)14.83
Current Ratio (mrq)4.25
Book Value Per Share (mrq)4.07

Cash Flow Statement

Operating Cash Flow (ttm)12.9M
Levered Free Cash Flow (ttm)10.11M